Trial Profile
Effect of Aliskiren on Circulating Endothelial Progenitor Cells and Vascular Function in Patients With Type 2 Diabetes and Essential Hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Hydrochlorothiazide
- Indications Essential hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Dec 2015 New trial record